The impact of selective serotonin reuptake inhibitors on bone mineral density in the pediatric and young adult population

2013 ◽  
Author(s):  
Feuer Alexis ◽  
Vogiatzi Maria
Keyword(s):  
Bone Mineral Density ◽  
Young Adult ◽  
Bone Mineral ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Adult Population ◽  
Serotonin Reuptake Inhibitors ◽  
Mineral Density ◽  
Young Adult Population ◽  
The Impact

Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change

2017 ◽  
Vol 37 (5) ◽  
pp. 524-530 ◽  
Author(s):  
Annelies C. Ham ◽  
Nikkie Aarts ◽  
Raymond Noordam ◽  
Fernando Rivadeneira ◽  
Gijsbertus Ziere ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Serotonin Reuptake Inhibitors ◽  
Density Change ◽  
Selective Serotonin ◽  
Bone Mineral Density Change ◽  
Mineral Density

Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women

2018 ◽  
Vol 21 (2) ◽  
pp. 193-199 ◽  
Author(s):  
Smita Saraykar ◽  
Vineeth John ◽  
Bo Cao ◽  
Matthew Hnatow ◽  
Catherine G. Ambrose ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Elderly Women ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Mineral Density

scholarly journals AB0950 EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS ON BONE MINERAL DENSITY IN EGYPTION PATIENTS WITH PRIMARY FIBROMYALGIA

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1772.3-1773
Author(s):  
Y. Gazar
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Trabecular Bone Score ◽  
Serotonin Reuptake Inhibitors ◽  
Control Group ◽  
Mineral Density ◽  
Old People ◽  
Primary Fibromyalgia

Background:Fibromyalgia is characterized by chronic widespread musculoskeletal pain that often co-exists with sleep disturbances, fatigue, cognitive dysfunction, stiffness and tenderness to palpation at specific tender points.Selective serotonin reuptake inhibitors represent a class of commonly used antidepressants. They act by preventing the reuptake of 5-hydroxytryptamine (5-HT) (Serotonin) through the inhibition of the 5-HT transporter (5-HTT) which is located on the presynaptic neuron, thereby increasing levels of 5-HT within the synaptic cleft and modulating neurochemical signaling.Usage of SSRIs was significantly associated with lumbar spine BMD reduction, particularly for old people.DXA and TBS revealed that usage of SSRIs and SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (partially degraded and degraded) particularly for old people. Conclusion: the present study provided evidence that usage of SSRIs or SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (Partially degraded and degraded) particularly for old people and despite low BMD was found in the SRI users; it also found in 1ry fibromyalgia not on SRIs so 1ry fibromyalgia should also be considered as a contributing factor for low BM.Objectives:This work aim to determine the correlation between selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) usage and bone mineral density (BMD) and trabecular bone score (TBS) changes in primary Fibromyalgia patientMethods:The present cross sectional study was conducted on a Hundred (100) Egyptian patients diagnosed as primary fibromyalgia divided according to drug medication into two 2 groups, 50 patients on SSRIs and 50patients on SNRIs, recruited from Rheumatology, Physical Medicine and Rehabilitation departments at AlHussein and Sayed Galal, Al-Azhar University Hospitals. In addition to another 50 age matched the control group subdivided into 25 primary fibromyalgia patients not on those drugs and 25 healthy individuals selected by nurses and medical staff, after an informed consent from all subjects from June 2018 to December 2018..An approval was obtained from the medical ethics committee of Al-Azhar University before starting this study. All the patients were informed about the study procedures and a written consent was obtained from all of them. The subjects were categorized into three groups. Group A: 50 1ry fibromyalgia patients on SSRI. Group B: 50 1ry fibromyalgia patients on SNRI. Group C: 50 individuals as a the control group subdivided into: group C-1: 25, 1ry fibromyalgia patients non SRIs-users and group C-2: 25) healthy individuals.Results:DXA and TBS revealed that usage of SSRIs and SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (partially degraded and degraded) particularly for old people. Conclusion: the present study provided evidence that usage of SSRIs or SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (Partially degraded and degraded) particularly for old people and despite low BMD was found in the SRI users; it also found in 1ry fibromyalgia not on SRIs so 1ry fibromyalgia should also be considered as a contributing factor for low BMDConclusion:The present study provided evidence that usage of SSRIs or SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (Partially degraded and degraded) particularly for old people and despite low BMD was found in the SRI users; it also found in 1ry fibromyalgia not on SRIs so 1ry fibromyalgia should also be considered as a contributing factor for low BMD. Keywords: SSRI, SNRI, FMS, fibromyalgia, osteoporosis, TBS, BMD, bone mineral density, trabecular bone score.Disclosure of Interests:None declared

Sign in / Sign up

Export Citation Format

Share Document